Meeting
2012 ASCO Annual Meeting
Comparative evaluation of capecitabine or infusional leucovorin/5-fluorouracil (LV/5-FU) with or without oxaliplatin (Ox) for stage III colon cancer (CC): A pooled analysis of individual patient data from four randomized controlled trials.
Authors
Weijing Sun
Abramson Cancer Center at the University of Pennsylvania, Philadelphia, PA
Weijing Sun , Hans-Joachim Schmoll , Michael O'Connell , Thomas H. Cartwright , Christopher Twelves , Edward McKenna , Wasif M. Saif , Luen F. Lee , Greg Yothers , Daniel G. Haller
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Discussion Session
Session Title
Gastrointestinal (Colorectal) Cancer
Track
Gastrointestinal Cancer—Colorectal and Anal
Sub Track
Colorectal Cancer
Citation
J Clin Oncol 30, 2012 (suppl; abstr 3525)
DOI
10.1200/jco.2012.30.15_suppl.3525
Abstract #
3525
Poster Bd #
17
Abstract Disclosures
Similar Posters
Poster
2013 Gastrointestinal Cancers Symposium
Effectiveness of capecitabine plus oxaliplatin for advanced colon cancer: A public hospital experience.
First Author: Carrie Luu
Poster
2012 ASCO Annual Meeting
Impact of age and medical comorbidity (MC) on adjuvant treatment outcomes for stage III colon cancer (CC): A pooled analysis of individual patient data from four randomized controlled trials.
First Author: Daniel G. Haller
Poster
2022 ASCO Gastrointestinal Cancers Symposium
Changes in prescribing patterns in stage III colon cancer (CC) since the IDEA collaboration.
First Author: Daniel Walden
Poster
2020 Gastrointestinal Cancers Symposium
The influence of adjuvant chemotherapy dose intensity on overall survival in resected colon cancer: A multicenter retrospective analysis.
First Author: Suganija Lakkunarajah